- IOVA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
Iovance Biotherapeutics (IOVA) S-8Registration of securities for employees
Filed: 18 Jun 15, 12:00am
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-8 pertaining to the Genesis Biopharma, Inc. 2011 Equity Incentive Plan and the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan of our reports dated March 16, 2015, relating to the financial statements and the effectiveness of internal control over financial reporting of Lion Biotechnologies, Inc. which appear in its Annual Report on Form 10-K for the year ended December 31, 2014, filed with the Securities and Exchange Commission.
/s/ WEINBERG & COMPANY, P.A.
Los Angeles, California
June 18, 2015
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.